Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Macromolecule-Loaded Hybrid Extracellular Vesicles via Ionic Lipid-Based Post-Loading for Intracellular Delivery: Functional Evaluation for Neurodegenerative Therapy

Cui L., Ono F., Ichinose T., Goto M., Ishihama K.

Laboratory Study on Neuroinflammation, published in J Extracell Biol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
J Extracell Biol (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42022851
PMCID
PMC13097689
DOI
10.1002/jex2.70125

Abstract (original English)

Extracellular vesicles (EVs) are natural carriers that show promise as drug delivery systems (DDS). We developed a non-invasive post-loading method to encapsulate macromolecules in EVs using our proprietary ionic lipid base (ILB), which enables electrostatically driver hybridisation without disrupting EV structure. Using EVs isolated from bovine milk and adipocyte-derived mesenchymal stem cell culture medium, hybrid-EVs (H-EV) with different ILB contents encapsulating protein or nucleic acid molecules for delivery were produced in a reproducible manner. The H-EV retained EV surface markers comparable to those of native EVs after preparation. After cellular uptake, the encapsulated molecules escaped from endosomes into the cytoplasm and exhibited intended functions. In an experiment using SH-SY5Y neuroblastoma cells in which α-synuclein (αSyn) aggregation was induced, the introduction of H-EV encapsulating anti-αSyn antibodies (Abs) significantly suppressed αSyn aggregation. Furthermore, delivery of anti-phospho-AKT Abs using H-EV promoted caspase 3/7 activity and cell apoptosis. Intravenous administration of H-EV encapsulating a model Ab into mice resulted in detectable Ab signals in the cerebral cortex, cerebellum, hippocampus and other cells associated with neurodegenerative diseases within 24 h, as assessed by ex vivo imaging. H-EV enabled loading of various molecules and th

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research